Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 1—January 2019

Prescription of Antibacterial Drugs for HIV-Exposed, Uninfected Infants, Malawi, 2004–2010

Alexander C. EwingComments to Author , Nicole L. Davis, Dumbani Kayira, Mina C. Hosseinipour, Charles van der Horst, Denise J. Jamieson, Athena P. Kourtis, and for the BreastfeedingAntiretrovirals and Nutrition study team
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (A.C. Ewing, N.L. Davis, D.J. Jamieson, A.P. Kourtis); University of North Carolina Project, Lilongwe, Malawi (D. Kayira); University of North Carolina, Chapel Hill, North Carolina, USA (M.C. Hosseinipour, C. van der Horst)

Main Article

Table 3

Respiratory indications for antibacterial drugs prescribed for HIV-exposed, uninfected infants in the Breastfeeding, Antiretrovirals and Nutrition study, Malawi, 2004–2010*

Condition No. (%)
Pneumonia 234 (6.81)
Acute respiratory infection or upper respiratory tract infection 2,291 (66.7)
Other* 912 (26.5)

*Otitis media, conjunctivitis, meningitis, sinusitis.

Main Article

1Team members are listed at the end of this article.

Page created: December 12, 2018
Page updated: December 12, 2018
Page reviewed: December 12, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.